204 related articles for article (PubMed ID: 8934161)
1. Evaluation of initial noninvasive therapy in pediatric patients presenting with suspected ulcer disease.
Olson AD; Fendrick AM; Deutsch D; Chernew ME; Hirth RA; Patel C; Bloom BS
Gastrointest Endosc; 1996 Nov; 44(5):554-61. PubMed ID: 8934161
[TBL] [Abstract][Full Text] [Related]
2. Alternative management strategies for patients with suspected peptic ulcer disease.
Fendrick AM; Chernew ME; Hirth RA; Bloom BS
Ann Intern Med; 1995 Aug; 123(4):260-8. PubMed ID: 7611591
[TBL] [Abstract][Full Text] [Related]
3. Immediate endoscopy or initial Helicobacter pylori serological testing for suspected peptic ulcer disease: estimating cost-effectiveness using decision analysis.
Fendrick AM; Chernew ME; Hirth RA; Bloom BS
Yale J Biol Med; 1996; 69(2):187-95. PubMed ID: 9112750
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the dyspeptic patient: a cost-utility study.
Ebell MH; Warbasse L; Brenner C
J Fam Pract; 1997 Jun; 44(6):545-55. PubMed ID: 9191627
[TBL] [Abstract][Full Text] [Related]
5. Review article: uninvestigated dyspepsia and non-ulcer dyspepsia-the use of endoscopy and the roles of Helicobacter pylori eradication and antisecretory therapy.
Chey WD; Moayyedi P
Aliment Pharmacol Ther; 2004 Feb; 19 Suppl 1():1-8. PubMed ID: 14725572
[TBL] [Abstract][Full Text] [Related]
6. Economic evaluation of empirical antisecretory therapy versus Helicobacter pylori test for management of dyspepsia: a randomized trial in primary care.
Jarbol DE; Bech M; Kragstrup J; Havelund T; Schaffalitzky de Muckadell OB
Int J Technol Assess Health Care; 2006; 22(3):362-71. PubMed ID: 16984065
[TBL] [Abstract][Full Text] [Related]
7. A cost analysis of alternative treatments for duodenal ulcer.
Imperiale TF; Speroff T; Cebul RD; McCullough AJ
Ann Intern Med; 1995 Nov; 123(9):665-72. PubMed ID: 7574221
[TBL] [Abstract][Full Text] [Related]
8. Management strategies for Helicobacter pylori-seropositive patients with dyspepsia: clinical and economic consequences.
Ofman JJ; Etchason J; Fullerton S; Kahn KL; Soll AH
Ann Intern Med; 1997 Feb; 126(4):280-91. PubMed ID: 9036800
[TBL] [Abstract][Full Text] [Related]
9. Immediate eradication of Helicobacter pylori in patients with previously documented peptic ulcer disease: clinical and economic effects.
Fendrick AM; McCort JT; Chernew ME; Hirth RA; Patel C; Bloom BS
Am J Gastroenterol; 1997 Nov; 92(11):2017-24. PubMed ID: 9362183
[TBL] [Abstract][Full Text] [Related]
10. Costs of managing Helicobacter pylori-infected ulcer patients after initial therapy.
Griffiths RI; Rabeneck L; Guzman G; Cromwell DM; Strauss MJ; Robinson JW; Winston B; Li T; Graham DY
Helicobacter; 2001 Mar; 6(1):66-76. PubMed ID: 11328368
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness modelling of use of urea breath test for the management of
Pritchard DM; Bornschein J; Beales I; Beresniak A; Salhi H; Malfertheiner P
BMJ Open Gastroenterol; 2021 Jul; 8(1):. PubMed ID: 34244244
[TBL] [Abstract][Full Text] [Related]
12. Guidelines for the management of dyspepsia.
Talley NJ; Vakil N;
Am J Gastroenterol; 2005 Oct; 100(10):2324-37. PubMed ID: 16181387
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of a 'score and scope' strategy for the management of dyspepsia.
García-Altés A; Rota R; Barenys M; Abad A; Moreno V; Pons JM; Piqué JM
Eur J Gastroenterol Hepatol; 2005 Jul; 17(7):709-19. PubMed ID: 15947547
[TBL] [Abstract][Full Text] [Related]
14. Serologic detection of CagA positive Helicobacter pylori strains predicts the presence of peptic ulcer in young dyspeptic patients.
Rokkas T; Liatsos C; Karameris A; Petridou E; Papatheodorou G; Kalafatis E
Gastrointest Endosc; 1999 Oct; 50(4):511-5. PubMed ID: 10502172
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of noninvasive testing and treatment strategies for H. pylori infection in children with dyspepsia.
Vakil N; Ashorn M
Am J Gastroenterol; 1998 Apr; 93(4):562-8. PubMed ID: 9576448
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of routine endoscopic biopsies for Helicobacter pylori detection in patients with non-ulcer dyspepsia.
Makris N; Crott R; Fallone CA; Bardou M; Barkun A
Gastrointest Endosc; 2003 Jul; 58(1):14-22. PubMed ID: 12838214
[TBL] [Abstract][Full Text] [Related]
17. Cost-benefit analysis of testing for Helicobacter pylori in dyspeptic subjects.
Sonnenberg A
Am J Gastroenterol; 1996 Sep; 91(9):1773-7. PubMed ID: 8792696
[TBL] [Abstract][Full Text] [Related]
18. Cost effectiveness of screening for and eradication of Helicobacter pylori in management of dyspeptic patients under 45 years of age.
Briggs AH; Sculpher MJ; Logan RP; Aldous J; Ramsay ME; Baron JH
BMJ; 1996 May; 312(7042):1321-5. PubMed ID: 8646042
[TBL] [Abstract][Full Text] [Related]
19. Clinical trial: a randomized trial of early endoscopy, Helicobacter pylori testing and empirical therapy for the management of dyspepsia in primary care.
Duggan AE; Elliott CA; Miller P; Hawkey CJ; Logan RF
Aliment Pharmacol Ther; 2009 Jan; 29(1):55-68. PubMed ID: 18801056
[TBL] [Abstract][Full Text] [Related]
20. Acid peptic diseases in the era of Helicobacter pylori.
Schoenfeld PS
Lippincotts Prim Care Pract; 1998; 2(4):358-68. PubMed ID: 9709081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
